Intrust Bank NA Has $561,000 Holdings in Danaher Co. (NYSE:DHR)

Intrust Bank NA decreased its holdings in Danaher Co. (NYSE:DHR) by 4.1% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 2,445 shares of the conglomerate’s stock after selling 104 shares during the period. Intrust Bank NA’s holdings in Danaher were worth $561,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Heck Capital Advisors LLC bought a new position in Danaher during the fourth quarter worth about $27,000. Decker Retirement Planning Inc. bought a new position in shares of Danaher during the 4th quarter worth approximately $31,000. Golden State Wealth Management LLC acquired a new stake in Danaher in the 4th quarter valued at $31,000. Strategic Financial Concepts LLC acquired a new position in Danaher during the fourth quarter worth $31,000. Finally, Pineridge Advisors LLC lifted its holdings in shares of Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after acquiring an additional 57 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Down 2.1 %

Shares of Danaher stock opened at $205.69 on Friday. Danaher Co. has a 1 year low of $196.80 and a 1 year high of $281.70. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The company has a market capitalization of $147.01 billion, a P/E ratio of 38.96, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. The business has a 50-day moving average of $214.57 and a two-hundred day moving average of $236.64.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period last year, the company earned $2.09 EPS. As a group, equities analysts predict that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.32 per share. This is a boost from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a dividend yield of 0.62%. The ex-dividend date is Friday, March 28th. Danaher’s dividend payout ratio (DPR) is currently 24.24%.

Analyst Upgrades and Downgrades

DHR has been the topic of several analyst reports. Robert W. Baird lowered their target price on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Scotiabank initiated coverage on Danaher in a research report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price objective for the company. Guggenheim assumed coverage on Danaher in a report on Thursday, December 19th. They set a “buy” rating and a $275.00 target price on the stock. Bank of America raised Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target for the company in a report on Friday, December 13th. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $277.00 price objective (down previously from $299.00) on shares of Danaher in a report on Thursday, January 30th. Five equities research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and a consensus price target of $278.24.

Insider Activity

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 11.10% of the stock is owned by corporate insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.